Claims
- 1. A process for the preparation of a dicarboxylate oxadiazine of Formula I which is racemic or enantiomerically enriched at the chiral center*,wherein:R1 is F, Cl or C1-C3 fluroalkoxy and R2 is C1-C3 alkyl comprising reacting a hydrazine carboxylate of Formula II with at least one molar equivalent of a di(C1-C3 alkoxy) methane in the presence of a protic acid catalyst in an inert solvent under conditions which allow for the prompt removal of the by-product alcohol by distillation.
- 2. A process of claim 1 wherein R1 is Cl and R2 is CH3.
- 3. A process of claim 1 wherein the protic acid is selected from p-toluenesulfonic acid, mixtures of the isomeric toluene sulfonic acids, benzene sulfonic acid, napthalene sulfonic acids, xylene sulfonic acids, methanesulfonic acid, sulfuric acid and camphor sulfonic acids.
- 4. A process of claim 1 wherein a catalytic amount of the protic acid is used.
- 5. A process of claim 1 wherein the dialkoxy methane used is a di(C2-C3 alkoxy) methane.
- 6. A process of claim 1 wherein the reaction temperature is from about 40-150° C. and at a pressure of about 1 atmosphere.
- 7. A process of claim 1 wherein the solvent is an inert non-halogenated solvent.
- 8. A process for preparing a compound of Formula I which is racemic or enantiomerically enriched at chiral center*wherein: R1 is F, Cl, or C1-C3 fluoroalkoxy, and R2 is C1-C3 alkyl, comprising: (a) reacting a compound of Formula III, which is racemic or enantiomerically enriched at*, with the compound of Formula IV in the presence of a protic acid catalyst in an inert solventH2N—NHCO2CH2(C6H5) IV to form a compound of Formula II and (b) reacting the compound of Formula II with a di(C1-C3 alkoxy) methane in the presence of the same protic acid catalyst and inert solvent as used in step (a) under conditions which allow for the prompt removal of the by-product alcohol by distillation.
- 9. A process of claim 1 further comprising the preparation of an arthropodicidal insecticide of Formula VII by(a) hydrogenating the compound of Formula I to form a compound of Formula V (b) reacting the compound of Formula V with the compound of Formula VI to form a compound of Formula VII having substantially the same absolute configuration as the compound of Formula I.
CROSS REFERENCE TO RELATED APPLICATIONS
This application was filed under 35 U.S.C. 371 from PCT/US97/13548, filed Jul. 31, 1997, which claims priority from U.S. Provisional application Ser. No. 60/022,426, filed Aug. 5, 1996.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
102e Date |
371c Date |
PCT/US97/13548 |
|
WO |
00 |
2/3/1999 |
2/3/1999 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO98/05656 |
2/12/1998 |
WO |
A |
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5500438 |
Barnette |
Mar 1996 |
|
Foreign Referenced Citations (4)
Number |
Date |
Country |
WO9211249 |
Jul 1992 |
WO |
WO9319045 |
Sep 1993 |
WO |
WO9529171 |
Nov 1995 |
WO |
95 29171 |
Nov 1995 |
WO |
Non-Patent Literature Citations (2)
Entry |
A. Fruchier et al., Ourverture d'epoxydes par le N-hydroxycarbamates de methyle; syntheses de tetrahydrodioxazine-1,4,2 ones-3 et de carbomethoxy-2 tetrahydrodioxazines-1,4,2, Bulletin de la Societe Chimique de France, Partie II, II-173-II-182, 1984. |
G. Picciola, Sintesi de Acidi Chinazolinonici e Genzossazinonici e Studio Delle Loro Proprieta Antiinfiammatorie, II Farmaco, Edizione Scientifica, 31, No. 9, 655-665, 1976. |
Provisional Applications (1)
|
Number |
Date |
Country |
|
60/022426 |
Aug 1996 |
US |